Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedSeveral key resources related to leukemia and treatment options have been removed, including links to MedlinePlus and various NIH disease pages, which may impact access to important medical information.SummaryDifference4%
- Check17 days agoChange DetectedNew resources related to leukemia and treatments, including links to MedlinePlus and NIH rare disease information, have been added, enhancing the site's informational offerings.SummaryDifference0.5%
- Check24 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check31 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.8%
- Check39 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check46 days agoChange DetectedDifference0.3%
Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.